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 Abstract:  
An expanded GGGGCC repeat in C9orf72 is the most common genetic cause of frontotemporal 
dementia and amyotrophic lateral sclerosis. A fundamental question is whether toxicity is driven 
by the repeat RNA itself and/or by dipeptide repeat proteins generated by repeat-associated, non-
ATG translation. To address this question we developed in vitro and in vivo models to dissect 
repeat RNA and dipeptide repeat protein toxicity. Expression of pure repeats in Drosophila 
caused adult-onset neurodegeneration attributable to poly-(glycine-arginine) proteins. Thus 
expanded repeats promoted neurodegeneration through neurotoxic proteins. Expression of 
individual dipeptide repeat proteins with a non-GGGGCC RNA sequence showed both poly-
(glycine-arginine) and poly-(proline-arginine) proteins caused neurodegeneration. These findings 
are consistent with a dual toxicity mechanism, whereby both arginine-rich proteins and repeat 
RNA contribute to C9orf72-mediated neurodegeneration. 
 
Main Text:  
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are adult-onset, 
neurodegenerative diseases associated with personality change, language dysfunction and 
progressive muscle weakness. These syndromes overlap genetically and pathologically, and can 
also co-occur in individuals, and within families (1). An intronic GGGGCC hexanucleotide 
repeat expansion in C9orf72 is the most common genetic cause of both FTD and ALS 
(C9FTD/ALS) (2-4), and can be found in patients diagnosed with all common neurodegenerative 
diseases (5). Healthy individuals carry fewer than 33 hexanucleotide repeats, with 2 repeats being 
the most common, but C9FTD/ALS cases carry between 400 and 4400 repeats (2, 5, 6). 
The repeat expansion could cause disease by three possible mechanisms: i) toxic sense and/or 
antisense repeat RNA species that sequester key RNA-binding proteins, ii) toxic dipeptide repeat 
(DPR) proteins, generated by repeat-associated, non-ATG (RAN) translation, or iii) reduced 
expression of C9orf72. The absence of a severe phenotype in a homozygous C9orf72 mutation 
case (7), and the lack of C9orf72 coding mutations (8) argue against loss-of-function as a primary 
mechanism. Neuronal aggregates of RNA, termed RNA foci, generated from both sense and 
antisense repeat transcripts are frequent in C9FTD/ALS patient brain (9-13). The GGGGCC 
repeat can be translated in all sense and antisense frames, two of which encode the same DPR, 
resulting in five DPR proteins, all of which form inclusions in widespread brain regions (10, 12, 
14-18). It is therefore of fundamental importance to understand the contributions of repeat RNA 
and DPR proteins to C9orf72-mediated neurodegeneration. 
A major obstacle in the investigation of large expanded repeats is that they are inherently 
unstable. We used recombination-deficient E. coli and a cloning strategy termed recursive 
directional ligation (19) to sequentially build seamless pure repeats from small GGGGCC repeat 
units (fig. S1). This allowed generation of a stable range of pure repeats from 3 to a maximum of 
103 (Fig. 1A).  To dissect repeat RNA and DPR protein toxicity, we generated “RNA-only” 
repeats, using our cloning strategy to insert interruptions containing stop codons in all sense and 
antisense frames. In models of other non-coding repeat expansion disorders, interruptions 
comprising 4 to 11 percent of the total repeat sequence confer stability while maintaining 
pathogenicity in vitro and in vivo (20-22). One of three 6-base-pair interruptions, each containing 
one stop codon in the sense and one in the antisense direction, were inserted every 12 GGGGCC repeats, resulting in a stop codon for all 6 (sense and antisense) frames, and interruptions that 
comprised 8% of the total sequence (fig. S2). We generated stop codon-interrupted RNA-only 
repeats equivalent in length to our pure repeats and longer RNA-only repeats up to ~288 (Fig. 
1A). GGGGCC repeat RNA forms a stable tertiary structure termed a G-quadruplex (23). 
Circular dichroism showed that the RNA-only repeats formed RNA G-quadruplexes similarly to 
pure repeat RNA (Fig. 1B), showing that the interruptions did not affect the tertiary structure of 
the RNA. To investigate the formation of RNA foci, constructs were expressed in human 
neuroblastoma cells. RNA fluorescence in situ hybridisation (FISH) showed that formation of 
RNA foci was length-dependent for both pure and RNA-only repeats which, at equivalent length, 
had the same propensity to form foci (Fig 1C, D).  
In order to differentiate between repeat RNA and DPR protein toxicity in vivo, we generated 
lines of the fruit fly Drosophila melanogaster carrying a range of our pure and RNA-only repeats 
under the UAS promoter, integrated into the same genomic location to ensure equivalent 
expression levels. When expressed specifically in the adult fly, the different repeats expressed 
sense transcripts at comparable levels and of the expected sizes, but no antisense transcripts (fig. 
S3A). RNA FISH showed that pure and RNA-only repeats were both able to generate RNA foci 
in Drosophila (fig. S4). Immunoblotting using an anti-poly-(GR) antibody (Fig. 2A) or an anti-
poly-(GP) antibody (fig. S5B) showed that, as expected, the pure repeats generated DPR proteins 
and the RNA-only repeats did not. Expression of both 36 and 103 pure repeats in the eye caused 
eye degeneration, whereas 36, 108 and ~288 RNA-only repeats had no effect under the same 
conditions (Fig. 2B). The toxicity of the pure repeats was thus attributable to the presence of DPR 
proteins. Increasing expression levels of the pure repeats, by increasing the temperature (24), led 
to lethality from both 36 and 103 repeats (Fig. 2C, fig S6) but for the RNA-only repeats had no 
effect, again demonstrating that the pure repeats caused lethality through the production of DPR 
proteins. 
The GMR-Gal4 driver is expressed throughout development. However, ALS and FTD are adult-
onset diseases. To circumvent developmental effects, we confined expression of the repeat 
constructs to adult neurons, using the inducible elav-GeneSwitch driver. Expression of 36 and 
103 repeats killed all flies by 30 days post-eclosion. 36, 108 and ~288 RNA-only repeats had no 
effect, showing that the neurotoxicity of the pure repeats was attributable to DPR protein 
production (Fig. 2D). To confirm this, we reduced protein synthesis in the 36 and 103 pure 
repeat-expressing flies with a sub-lethal dose of cycloheximide, which ameliorated the reduction 
in lifespan caused by the pure repeats (Fig. 2E), again showing that toxicity was attributable to 
DPR proteins.  
To assess whether DPR protein expression alone was sufficient for toxicity, “protein-only” 
constructs were generated, by using alternative codons to those found within the GGGGCC 
repeat. We compared the two arginine-containing DPR proteins, glycine-arginine (GR) and 
proline-arginine (PR), with two neutral DPR proteins, proline-alanine (PA) and glycine-alanine 
(GA). When constructs containing 36 dipeptide repeats (equivalent to 36 pure GGGGCC repeats) 
were expressed in the fly eye, the arginine-containing DPR proteins GR and PR caused eye 
degeneration and lethality, while GA and PA DPR proteins had no effect (Fig. 3A, C). Thus, the 
arginine-containing DPR proteins induced toxicity. We next generated longer protein-only 
sequences, of equivalent length to 103 pure repeats. Expression of (PR)100 or (GR)100 caused eye degeneration and increased lethality, while (PA)100 and (GA)100 had no effect  (Fig. 3B, C). 
Expression of (PR)100 and (GR)100 in adult neurons caused a substantial decrease in survival (Fig. 
3D); a late-onset reduction in survival was also observed in (GA)100-expressing flies, while  
(PA)100 had no effect. Expression levels varied among the individual protein-only constructs, but 
did not correlate with toxicity (fig. S3C), which was therefore attributable to the arginine-rich 
sequences. Thus, the highly basic arginine-containing DPR proteins drove C9orf72 GGGGCC 
repeat toxicity in Drosophila neurons.   
Our data identified GR and PR DPR proteins as the predominant toxic protein species, although 
all five DPR proteins form inclusions in affected brain regions. Similarly, the distribution of 
poly-(GA) inclusions does not correlate well with neurodegeneration (25). The presence of 
arginine in both of the highly toxic DPR species suggests a common pathological mechanism, 
perhaps attributable to their basic nature or a common structural motif. Restricted expression of 
C9orf72 to specific neuronal populations (26), or a deficit in the affected neurons’ ability to clear 
these particular proteins, may explain why these highly toxic proteins cause selective 
neurodegeneration. In patients all five DPR proteins may be produced in a single neuron. While 
our findings indicate that toxicity is driven by the arginine-rich DPR proteins it remains possible 
that high focal levels of the other DPR proteins could contribute to cytotoxicity.   
We have been able to separate RNA and DPR toxicity associated with C9orf72 GGGGCC 
repeats and, surprisingly, our data suggests that the major toxic species are the DPR proteins. 
However, the DPR protein toxicity that we observed from over-expression of pure repeats does 
not rule out an additional contribution of RNA toxicity. Several lines of evidence suggest a toxic 
role of repeat RNA. In C9FTD patient brain, RNA foci are most abundant in the frontal cortex, 
which has the greatest degree of neuronal loss, and frontal cortex RNA foci burden correlates 
with age at onset in C9FTD cases (9). GGGGCC repeats also sequester several RNA-binding 
proteins, which could lead to toxicity (13, 27-31). However, modelling RNA toxicity may require 
longer repeats that are closer to the pathological range seen in disease, possibly because a toxic 
threshold of repeat number must be crossed. A continuing conundrum is why the same expanded 
repeat can cause either pure FTD or pure ALS. Our data raise the possibility that the different 
patient phenotypes could be caused by differences in the relative contributions of RNA or 
protein-mediated toxicity within distinct neuronal subtypes. A further prediction from this 
hypothesis is that genetic variants that affect RAN translation or DPR protein levels may also 
contribute to disease penetrance.  
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Fig. 1. Generation and characterisation of expanded pure and RNA-only GGGGCC 
repeats. (A) Agarose gel showing pure GGGGCC repeats and stop codon-interrupted RNA-only 
(RO) repeats. (B) Circular dichroism (CD) spectra of both 24 pure and 24 RO repeats showed 
characteristic RNA G-quadruplex structure with minima and maxima at 237 and 262 nm 
respectively (23). (C) Confocal microscope images of nuclei (blue) in RNA FISH-labelled SH-
SY5Y cells showed that 103 pure and 107 RO repeats both produced nuclear RNA foci (red). 
Scale bar represents 5 µm. (D) Quantification of the number of SH-SY5Y cells containing RNA 
foci after transfection with pure and RO repeats of different lengths, and empty vector (E). No 
difference was observed between equivalent length pure and RNA-only repeats (36 vs. 36 RO, 
103 vs. 107 RO, 1 way ANOVA with Bonferroni test (selected pairs), n > 3, error bars represent 
SEM).  
 
Fig. 2. Pure GGGGCC repeats caused toxicity via DPR proteins. (A) Dot blot showing that 
36 and 103 pure repeats generated poly-(GR) proteins while 3 pure repeats, and 36, 108 and ~288 
RNA-only (RO) repeats did not. Genotypes were: w; UAS-3/hsGal4, w; UAS-36/hsGal4, w; 
UAS-103/ hsGal4, w; UAS-36 RO/hsGal4, w; UAS-108 RO/ hsGal4, w; UAS-288 RO/hsGal4. (B) 
Stereomicroscopy images of representative Drosophila eyes expressing pure or RO repeats using 
the GMR-GAL4 driver. 36 pure repeats were mildly toxic. 103 pure repeats showed more overt 
toxicity. 3 repeats and 36 and 108 RO repeats had no effect. Genotypes were: w; GMR-Gal4/+, 
w; GMR-Gal4/UAS-3, w; GMR-Gal4/UAS-36, w; GMR-Gal4/UAS-103, w; GMR-Gal4/UAS-
36RO, w; GMR-Gal4/UAS-108RO, w; GMR-Gal4/UAS-288RO. Scale bar represents 200 µm. (C) 
Quantification of egg-to-adult viability showed that 36 and 103 pure repeats were lethal at higher 
temperatures, whereas RO repeats had no effect (Kruskal Wallis test with Dunn's multiple 
comparison (selected pairs), ***p<0.001, **p<0.01, *p<0.05, error bars represent SEM). 
Genotypes were as in (B). (D) Survival of female flies expressing repeats in adult neurons using 
the elav-GeneSwitch (elavGS) driver. 36 and 103 pure repeats substantially decreased survival, 
while 36, 108 and 288 RO repeats had no effect (p<0.0001, log-rank test). Genotypes were: w; 
UAS-3/+; elavGS/+, w; UAS-36/+; elavGS/+, w; UAS-103/+; elavGS/+, w; UAS-36 RO/+; 
elavGS/+, w; UAS-108 RO/+; elavGS/+, w; UAS-288 RO/+; elavGS/+. (E) Flies expressing 36 
and 103 pure repeats survived longer in the presence of cycloheximide than in its absence 
(p<0.001, log-rank test). Genotypes were: w; UAS-36/+; elavGS/+, w; UAS-103/+; elavGS/+.   
 
 
Fig. 3. DPR toxicity was caused by poly-GR and poly-PR proteins. “Protein-only” constructs 
for individual DPR proteins were expressed in the Drosophila eye (A-C), and the adult nervous 
system (D). (A) (GR)36 and (PR)36 caused eye degeneration, while (GA)36 and (PA)36 had no 
effect. Genotypes were: w; UAS-PA36/GMR-Gal4, w; UAS-GA36/GMR-Gal4, w; UAS-
GR36/GMR-Gal4, w; UAS-PR36/GMR-Gal4. Scale bar represents 200 µm. (B) (GR)100 and 
(PR)100 caused extensive eye degeneration, while (GA)100 and (PA)100 had no effect. Genotypes 
were: w; UAS-PA100/GMR-Gal4, w; UAS-GA100/GMR-Gal4, w; UAS-GR100/GMR-Gal4, w; 
UAS-PR100/GMR-Gal4. (C) Quantification of egg-to-adult viability showed (GR)100 and (PR)100 
caused a substantial reduction in survival, whereas (GA)100 and (PA)100 had no effect (Kruskal 
Wallis test with Dunn's multiple comparison, selected pairs, ***p<0.001, **p<0.01, error bars 
represent SEM). Genotypes were as in (A) and (B). (D) Expression of (GR)100 and (PR)100 in 
adult neurons using the elav-GeneSwitch (elavGS) driver caused a substantial decrease in 
viability (p<0.001, log-rank test); (GA)100 caused a late-onset decrease in survival, and (PA)100 or 
elavGS driver alone had no effect. Genotypes were: w; elavGS/+, w; UAS-PA100/+; elavGS/+, 
w; UAS-GA100/+; elavGS/+, w; UAS-GR100/+; elavGS/+, w; UAS-PR100/+; elavGS/+.    
  
 
 
Supplementary Materials for 
 
C9orf72 repeat expansions cause neurodegeneration in Drosophila through 
arginine-rich proteins 
Sarah Mizielinska,
1* Sebastian Grönke,
2* Teresa Niccoli,
3* Charlotte E. Ridler,
1 Emma L. 
Clayton,
1 Anny Devoy,
1 Thomas Moens,
1,3 Frances E. Norona,
1 Ione O.C. Woollacott,
1 Julian 
Pietrzyk,
1 Karen Cleverley,
1 Andrew J. Nicoll,
1,4 Stuart Pickering-Brown,
6 Jacqueline Dols,
2 
Melissa Cabecinha,
3 Oliver Hendrich,
2 Pietro Fratta,
1,5 Elizabeth M.C. Fisher,
1,5 Linda 
Partridge,
2,3† Adrian M. Isaacs
1† 
†Corresponding authors. E-mail: a.isaacs@prion.ucl.ac.uk; l.partridge@ucl.ac.uk 
 
This PDF file includes: 
 
Materials and Methods 
Figs. S1 to S7 
Full reference list 
 Materials and Methods 
 
Generation of repeat constructs 
A range of increasing repeat sizes was generated using recursive directional ligation 
(RDL, (19), see fig. S1). Complementary DNA oligonucleotides (Sigma) containing 3 or 4 
GGGGCC repeats, flanked 5’ by BamHI and BspQI recognition sites and 3’ by EcoO109I and 
NotI recognition sites, were annealed and ligated into the vector pBluescript using the BamHI 
and NotI sites. Oligomerization of repeat units was achieved by digestion of the vector with 
BspQI and EcoO109I (both NEB) to release an insert, followed by ligation into the vector, which 
had been linearized by digestion with only BspQI. Additional rounds of RDL proceeded 
identically, using the product from the previous round as the starting material. Repeat units were 
joined seamlessly, with no interruption of the GGGGCC repeat sequence, and loss of the BspQI 
and EcoO109I recognition sites at the site of ligation due to their non-palindromic overhangs. 
Repeat constructs were subcloned into pcDNA3.1(+) or pUAST attB for expression in 
neuroblastoma cells or Drosophila, respectively. Protein-only alternative codon constructs were 
synthesised (GeneArt, Life Technologies) and subcloned into pUAST attB as above (sequences 
available on request). Transformations were performed using recombination-deficient Stbl3 E. 
coli (Life Technologies) at 30°C to minimize retraction of repeats. DNA was extracted using 
QIAprep Spin Miniprep or Plasmid Maxi kits (QIAGEN), following the manufacturer’s 
instructions. Constructs were screened using standard restriction enzyme digest and agarose gel 
electrophoresis, and were sequence-verified (Source Bioscience) using dGTP BigDye (Applied 
Biosystems) up to 108 repeats, to confirm repeat size and interruptions.    
 
Circular Dichroism (CD) 
An HPLC-purified RNA oligonucleotide of 24 pure or 24 RNA-only repeats (IDT) was 
annealed by heating the samples to 90°C and allowing them to cool overnight to 20°C. CD 
experiments were performed at 25°C in 40 mM KCl, 10 mM potassium phosphate, pH 7.0 buffer 
using a Jasco J715 spectropolarimeter (Jasco Hachioji, Tokyo, Japan). A CD spectrum of the 
buffer was recorded and subtracted from the spectrum obtained for the RNA-containing solution. 
Data were zero-corrected between 340–350 nm. 
 
Cell culture and transfection 
The human neuroblastoma cell line SH-SY5Y was grown using standard cell culture 
techniques in supplemented DMEM media (10% FCS, 5 mM L-glutamine, 1 mM sodium 
pyruvate (Life Technologies)) in a 37°C/5% CO2 incubator. Cells were plated on glass coverslips 
in a 24-well dish at a density of 1.5x10
-4 cells per well. The following day, cells were transfected 
using Lipofectamine2000 (Life Technologies), according to the manufacturer’s instructions, 
using 0.4 ng of DNA, 0.04 ng of the co-transfection marker ZsGreen (pBI-CMV3, Clontech) and 
1 μl Lipofectamine2000, each diluted in 30 μl of OptiMEM (Life Technologies) per well. Cells 
were incubated with transfection mix for 3 hours at 37°C/5% CO2, washed once, and returned to 
fresh culture medium. Expression was analysed 24 hours later.  
 
Generation and maintenance of transgenic fly lines 
Transgenic fly lines were generated by phiC31-integrase-mediated, site-directed insertion 
into the attP40 locus (32). Constructs were injected into y1, M{vas-int.B}ZH-2A w*; P{CaryP}attP40 embryos and the phiC31 integrase was removed by crossing transgenic males to 
white females for two successive generations. Integration into the attP40 landing site was 
verified by PCR using primers SOL734 (GGAACCTTACTTCTGTGGTGTGAC) and SOL459 
(AATTCGGGGGCTTTCGGTGTT), which bind in the SV40 3´ UTR of the pUAST attB vector 
and in the genomic region flanking the attP40 insertion site, respectively.  
All fly stocks were maintained at 25°C on a 12:12 hour light:dark cycle at constant 
humidity on a standard sugar-yeast (SY) medium (15 g/L agar, 50 g/L sugar, 100 g/L autolysed 
yeast, 30 ml/L nipagin (10% in ethanol) and 3 ml/L propionic acid). Elav-GeneSwitch (elavGS) 
(33) and daughterless-GeneSwitch (daGS) (34) flies were obtained as a generous gift from Dr H. 
Tricoire (CNRS, France). The GMR-Gal4, attP40 and vas phiC31 integrase lines were obtained 
from the Bloomington Drosophila Stock Centre.  
 
Northern Blotting 
To induce adult-specific, ubiquitous expression of GGGGCC repeats or DPR protein-
only constructs, daughterless-GeneSwitch (da-GS) driver flies were crossed to the corresponding 
UAS lines. da-GS/UAS flies were fed for 5 days with 200 µM mifepristone (RU486) to induce 
expression. RNA was extracted using Trizol and the Qiagen RNeasy Mini Kit with on-column 
DNase-treatment. Northern blots were performed using the Northern Max Kit (Ambion) 
according to the manufacturer’s instructions, using 20 µg total RNA per lane. A (GGCCCC)5 
oligonucleotide probe was used to detect sense repeats and a (GGGGCC)5 oligonucleotide probe 
was used to detect antisense repeats. DPR protein-only constructs were detected using an 
oligonucleotide probe (CATGGTGGGATCCGAATTCCCAATTCCCT), targeted to a sequence 
in the 5´ UTR common to all DPR protein-only constructs. Oligonucleotides were end-labelled 
with T4 Polynucleotide Kinase and γ32-P-ATP. Hybridisation was performed using Ultrahyb-
Oligo hybridisation buffer (Ambion) at 42°C overnight. Membranes were washed twice with 
2xSSC at 42°C and then exposed to X-ray films. For normalization, blots were re-hybridised 
with a probe detecting ribosomal protein RpL32 transcripts. For control dot blots, (GGCCCC)5 
and (GGGGCC)5 oligonucleotides were bound to a bright star plus nylon membrane (Ambion) 
and co-hybridised with the corresponding northern blots. 
 
RNA fluorescent in situ hybridisation  
Neuroblastoma cell lysates – 24 hours after transfection, cells were fixed in 4% 
paraformaldehyde (in PBS) for 10 minutes, washed briefly in 2xSCC, and then incubated in pre-
hybridisation solution (40% formamide, 2xSSC) for 30 minutes at 37°C. Hybridisation using a 
Cy3-labelled (GGCCCC)4 RNA probe (IDT) (0.4 ng/μl probe, 40% formamide, 2xSSC, 0.2% 
BSA, 1 mg/ml salmon sperm DNA, 1 mg/ml tRNA, 10% dextran sulphate, 2 mM vanadyl 
ribonucleoside) was performed at 37°C for 2 hours in a humidified chamber. This was followed 
by three 20-minute washes (40% formamide, 2xSCC) at 37°C with shaking, and three 10-minute 
washes (2xSCC) at room temperature. Samples were mounted using ProLong Gold antifade 
reagent, which includes DAPI (Life Technologies).  
Drosophila – Salivary glands from fly larvae heat-shocked at 37°C for 1.5 hours and 
allowed to recover for 3 hours at 25°C were dissected in PBS and fixed in 4% paraformaldehyde 
(in PBS) for 20 minutes, washed 3 times in PBS-T (PBS containing 0.3% Tween), and then 
placed in methanol at -20°C for at least 12 hours. Samples were re-hydrated in a methanol 
gradient back to PBS, treated with 0.5 μg/ml proteinase K (in 50 mM Tris, 50 mM EDTA) for 1 
hour at room temperature, then washed in PBS, followed by 2xSSC. Samples were then incubated in pre-hybridisation solution (50% formamide, 2xSSC) for 30 minutes at 80°C. 
Hybridisation using an Alexa488-labelled (GGCCCC)4 RNA probe (IDT) (0.2 ng/μl probe, 50% 
formamide, 2xSSC, 0.02% BSA, 1 mg/ml salmon sperm DNA, 1 mg/ml tRNA, 10% dextran 
sulphate, 1.6 mM vanadyl ribonucleoside) was performed at 80°C for 2.5 hours. This was 
followed by three 10-minute washes (50% formamide/0.2xSCC) at 80°C, three 10-minute 
washes (0.2xSCC) at room temperature, and then briefly in PBS. Samples were mounted using 
Vectashield (Vector Labs), which includes DAPI. 
 
Imaging and quantification of RNA foci 
Neuroblastoma cell lysates - Fifteen 40× z-stack images per coverslip were taken at high 
resolution (2048×2048 pixels) using a 1.4 NA objective on a confocal microscope (LSM710, 
Zeiss) to yield a minimum of 100 transfected cells for analysis. Quantification of foci was 
performed using Volocity image analysis software (Perkin Elmer) on maximum intensity 
projections of each z-stack. ZsGreen-positive cells, DAPI-stained nuclei and RNA foci were 
identified by fluorescence intensity, using the same threshold for all images; objects smaller than 
0.05 μm
2 or larger than 6 μm
2 were excluded for RNA foci analysis. Presence of RNA foci in 
transfected cells was determined by co-localisation with DAPI and compartmentalisation into 
ZsGreen-positive cells. Data are presented as the percentage of transfected cells containing RNA 
foci. 
Drosophila – One 40× z-stack image was taken per salivary gland at high resolution 
(2048×2048 pixels) using a 1.4 NA objective on a confocal microscope (LSM710, Zeiss). RNA 
foci-positive nuclei were counted and used to calculate the percentage of foci-positive cells per 
salivary gland. 
 
Immunoblotting 
DPR Antibodies – Anti-poly-(GP) antibody was generated by immunising rabbits with a 
(GP)7-LPH (limulus polyphemus hemocyanin) fusion protein (Biogenes). Resulting antiserum 
was purified against the immunisation peptide (Biogenes) producing a monospecific antibody to 
poly-(GP). Anti-poly-(GR) antibody was rabbit polyclonal 23978-1-AP from Proteintech. 
Drosophila – For western blotting, adult flies were fed for 4 days with 200 µM 
mifepristone (RU486) to induce expression. Fly heads were homogenised in 2x Laemmli sample 
buffer (4% SDS, 20% glycerol, 120 mM Tris-HCl pH6.8, 200 mM DTT with bromophenol blue) 
and heated to 95°C
 for 5 minutes. Samples were separated on 4-12% NuPAGE Bis-Tris gels 
(Invitrogen) and transferred to Immobilon membrane (Millipore). The membrane was blocked in 
5% milk in TBS containing 0.05% Tween-20 (TBS-T) for 1 hour and then probed with rabbit 
anti-poly-(GP) antibody (1:1000 in TBS-T) at 4°C overnight, or with mouse anti-actin antibody 
(ab8224, Abcam) for 2 hours at room temperature. HRP-conjugated anti-mouse and anti-rabbit 
secondary antibodies (ab6789 and ab6721, Abcam) were used. Bands were visualized with 
Luminata Forte (Millipore) and imaged with ImageQuant LAS4000 (GE Healthcare Life 
Sciences).  
To identify poly-(GR) DPR proteins, dot blots were used, due to the difficulty of 
analysing highly positively-charged proteins with SDS-PAGE. Heads and thoraxes were 
dissected from adult flies heat-shocked for 1.5 hours and allowed to recover for 24 hours, 
homogenised in RIPA buffer with protease inhibitors (cOmplete protease inhibitor cocktail 
without EDTA, Roche), and heated to 95°C for 5 minutes (5 µl of buffer per fly). An aliquot was 
taken at this point, added in equal amounts to 2x Laemmli sample buffer and heated to 95°C for 
5 minutes. This was used to dot blot for the actin loading control. The rest of the sample was treated with 10 µg/ml of proteinase K at 37°C for 30 minutes, added in equal amounts to 2x 
Laemmli sample buffer, and heated to 95°C for 5 minutes. Samples (2 µl) were blotted onto dry 
nitrocellulose membrane and allowed to dry for 15 minutes. Membranes were processed as 
above, probed with rabbit anti-poly-(GR) antibody (1:1000 in TBS-T). 
Neuroblastoma cell lysates – 24 hours after transfection, cells were washed briefly in 
PBS, lysed in 2x Laemmli Sample Buffer (as above) and heated to 95°C
 for 10 minutes. Samples 
were separated on 4-12% NuPAGE Bis-Tris gels (Invitrogen) and transferred to Immobilon 
membrane (Millipore). The membrane was blocked in 5% milk in PBS containing 0.05% 
Tween-20 (PBS-T) for 1 hour and then probed with rabbit anti-poly-(GP) antibody (1:2000 in 
1% BSA/PBS-T) or rabbit anti-poly-(GR) antibody (1:1000 in 1% BSA/PBS-T) for 2 hours at 
room temperature. HRP-conjugated anti-rabbit secondary antibody (1:5000, Jackson 
ImmnoResearch) was used and bands visualized with SuperSignal West Pico Chemiluminescent 
Substrate (Thermo Scientific). For loading control, the membrane was stripped using Restore 
Western Blot Stripping Buffer (Thermo Scientific), blocked in 5% milk in PBS-T, re-probed 
with rabbit anti-GFP antibody (1:5000 in PBS-T, A-11122, Life Technologies), and continued as 
above. 
 
Egg-to-adult viability assay and eye phenotypes 
Three virgin GMR-Gal4 females were crossed with three UAS males, and flies were 
allowed to lay eggs for 12-16 hours at 25°C on SYA food. Eggs were counted, and then vials 
were incubated at 25°C, 27°C or 29°C to increase GAL4-mediated overexpression (24). Adult 
flies were counted, and viability was calculated by dividing the number of adult flies by the 
number of eggs. 10 replicates per genotype and temperature were used, n = >400 flies per 
condition.  
Eye images of 1-day-old flies expressing repeats or DPR proteins under the control of the 
GMR-Gal4 driver were taken using a Leica M165 FC stereomicroscope equipped with a 
motorized stage and a multifocus tool (Leica application suite software). 20 images per fly eye 
were taken per genotype and treatment. 
 
Lifespan assay 
Flies were reared at a standard density on SY medium at 25°C. Two days after eclosion 
flies were allocated to experimental vials at a density of 10-15 flies per vial (total of 100-150 
flies per condition) containing SY medium with or without 200 µM mifepristone (RU486) to 
induce expression. To reduce protein synthesis in flies, cycloheximide was added to the medium 
at a concentration of 28 mg/L, together with RU486 (200 µM). Flies were transferred to fresh 
vials 3 times per week and, at the same time, deaths in each vial were scored. Data are presented 
as survival curves and comparison between groups was performed using a log-rank test. For 
simplicity only induced flies are presented in the main text, uninduced controls are presented in 
fig. S7.  
 
Fig. S1. GGGGCC repeat cloning strategy.  
A range of GGGGCC repeat sizes was generated using recursive directional ligation (RDL) (19). 
Initial inserts containing 3 or 4 GGGGCC repeats were designed with recognition sites for BspQI 
(5’) and EcoO109I (3’), which produce compatible overhangs when digested. Oligomerization of 
repeat units was achieved by digestion of the vector with both BspQI and EcoO109I to release an 
insert (1), followed by ligation into the vector, which had been linearized by digestion with only 
BspQI (2). The product contained one (or more) inserts of the original repeat unit, with the 
restriction recognition sites only maintained at the end of the full insert (3). Additional rounds of 
RDL proceeded identically, using the product from the previous round as the starting material 
(4). Repeat units were joined seamlessly, with no interruption of the GGGGCC repeat sequence, 
and loss of the BspQI and EcoO109I recognition sites at the site of ligation (5).  
 
 
 
Fig. S2. Schematic of RNA-only repeat construct design.  
To dissect repeat RNA and DPR protein toxicity, three 6-base-pair interruptions were designed, 
each containing one stop codon in the sense and one in the antisense direction, and inserted 
sequentially using recursive directional ligation, described in fig. S1. The resulting RNA-only 
repeat constructs contained 6-base-pair interruptions every 12 GGGGCC repeats with a stop 
codon in each sense and antisense frame every 36 repeats.   
 
Fig. S3. GGGGCC repeat and DPR protein-only expression in Drosophila.  
(A) Northern blotting using a (GGCCCC)5 probe to detect sense repeats confirmed that pure and 
RNA-only (RO) repeat transcripts were expressed at similar levels and that their relative sizes 
were as expected. Hybridisation with a (GGGGCC)5 probe did not detect antisense transcripts. A 
probe for RpL32 (lower panel) confirmed equal loading of the gel. All repeat-containing RNA 
ran at a higher molecular weight than predicted, likely due to the repeat sequence retarding 
progression through the gel. Genotypes were: w; UAS-36/daGS, w; UAS-36 RO/daGS, w; UAS-
103/daGS, w; UAS-108RO/daGS, w; UAS-288RO/daGS. (B) Control dot blot for the 
(GGCCCC)5 antisense probe and  the (GGGGCC)5 sense probe confirmed that both probes 
specifically detected the corresponding (GGGGCC)5 sense and (GGCCCC)5 antisense 
oligonucleotide, respectively. (C) Northern blotting with a probe that targets a common sequence 
in the 5´ UTR confirmed expression of 36 and 100 protein-only DPRs. GR and GA constructs 
were expressed at higher levels than PA and PR constructs. Equal RNA loading was controlled 
by an RpL32 probe (lower panel). Genotypes were: w; UAS-PA(36)/daGS, w; UAS-
PA(100)/daGS, w; UAS-GA(36)/daGS, w; UAS-GA(100)/daGS, w; UAS-GR(36)/daGS, w; UAS-
GR(100)/daGS, w; UAS-PR(36)/daGS, w; UAS-PR(100)/daGS.  
 
Fig. S4. Pure and RNA-only GGGGCC repeats generated RNA foci in Drosophila. 
A heat-shock GAL4 (hsGal4) driver was used to express 3 and 103 pure repeats, and 108 RNA-
only (RO) repeats in Drosophila salivary glands, chosen because of their large nuclei, which 
allowed visualisation of RNA foci. (A) RNA FISH detected RNA foci (green) within nuclei 
(blue) in flies expressing 103 pure repeats and 108 RO repeats, but not in flies expressing 3 
repeats. Scale bar represents 5 μm. (B) Quantification of the percentage of salivary gland cells 
containing nuclear RNA foci. Each dot represents an individual salivary gland. Since the hsGal4 
is a lethal insertion, heterozygous driver lines were crossed to homozygous UAS lines. The 
salivary glands of the progeny were scored without genotyping, therefore only 50% of samples 
are expected to express the repeat constructs and RNA foci are expected in a maximum of 50% 
of flies. N = >250 nuclei (12-27 salivary glands). The crosses were: hsGal4/CyO males crossed 
to females of the following genotypes: w; UAS-3, w; UAS-100, w; UAS-108RO.  
 
Fig. S5. Poly-(GP) proteins were generated by Drosophila expressing pure, but not RNA-
only repeats. 
(A) Characterisation of poly-(GP) (generated by Biogenes) and poly-(GR) (23978-1-AP from 
Proteintech) antibodies by immunoblotting of neuroblastoma cell line lysates expressing GFP-
tagged alternative codon DPR proteins or GFP alone. Blotting showed specific binding of each 
antibody. Blotting with anti-GFP antibody confirmed expression of all constructs. (B) Pure or 
RNA-only (RO) repeats were expressed in Drosophila adult neurons using the elav-GeneSwitch 
(elavGS) driver. Immunoblots were performed on fly head protein extracts with anti-poly-(GP) 
antibody, confirming that 36 and 103 pure repeats generated GP DPR protein, and RNA-only 
repeats did not. Loading control was performed with anti-actin antibody. Genotypes were: w; 
UAS-3/+; elavGS/+, w; UAS-36/+; elavGS/+, w; UAS-103/+; elavGS/+, w; UAS-36 RO/+; 
elavGS/+, w; UAS-108 RO/+; elavGS/+, w; UAS-288 RO/+; elavGS/+. 
 
Fig. S6. Temperature-dependent increase in expression exacerbated toxicity of pure 
GGGGCC repeats. 
Increasing the temperature to 29°C caused severe rough eye phenotypes when 36 and 103 pure 
repeats were expressed in the Drosophila eye using the GMR-Gal4 driver. Eye-specific 
expression of RNA-only (RO) repeats caused no phenotype even at 29°C, when compared to 
GMR/+ or 3 pure repeat controls. GMR driver alone caused mild toxicity at 29°C, as previously 
described (35). Genotypes were w; GMR-Gal4/+, w; GMR-Gal4/UAS-3, w; GMR-Gal4/UAS-36, 
w; GMR-Gal4/UAS-36RO, w; GMR-Gal4/UAS-103, w; GMR-Gal4/UAS-108RO, w; GMR-
Gal4/UAS-288RO. Scale bar represents 200 μm.   
 
Fig. S7. Control survival curves for uninduced Drosophila.  
Survival of uninduced female control flies for lifespans shown in Fig. 2D (A) and 3D (B). (A) 
While median lifespan was not significantly decreased in elav-GeneSwitch (elavGS) driver 
alone, 3 pure repeats, or 36, 108 and 288 RNA-only (RO) repeat flies compared to their 
respective uninduced control flies, 36 and 103 pure repeat-expressing flies showed a 
significantly decreased survival compared to their uninduced controls (p<0.0001, log-rank test). 
Genotypes were: w; UAS-3/+; elavGS/+, w; UAS-36/+; elavGS/+, w; UAS-103/+; elavGS/+, w; 
UAS-36 RO/+; elavGS/+, w; UAS-108 RO/+; elavGS/+, w; UAS-288 RO/+; elavGS/+. (B) 
There was no significant difference in survival between induced and uninduced elavGS driver 
only or PA100 flies. In contrast, survival was substantially decreased in GA100-, GR100- and 
PR100-expressing flies compared to their corresponding uninduced controls (p<0.0001, log-rank 
test). Genotypes were: w; elavGS/+, w; UAS-PA100/+; elavGS/+, w; UAS-GA100/+; elavGS/+, 
w; UAS-GR100/+; elavGS/+, w; UAS-PR100/+; elavGS/+.    
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